Publications & Articles
No Category Subject Journal Writer Publication year
37631 Oncology; Respiratory System Real world data of durvalumab consolidation after chemoradiotherapy in... LUNG CANCER 2020 10.1016/j.lungcan.2020.05.035 박근칠 2020
37630 Oncology Biomarker-driven phase 2 umbrella trial study for patients with recurr... CANCER 2020 10.1002/cncr.33048 박근칠 2020
37629 Cardiac & Cardiovascular Systems; Respiratory System; Surgery Utility of positron emission-computed tomography for predicting pathol... EUR J CARDIO-THORAC 2020 10.1093/ejcts/ezaa181 박근칠 2020
37628 Oncology; Respiratory System The different central nervous system efficacy among gefitinib, erlotin... TRANSL LUNG CANCER R 2020 10.21037/tlcr-20-379 박근칠 2020
37627 Critical Care Medicine; Respiratory System Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell l... LANCET RESPIR MED 2020 10.1016/S2213-2600(20)30154-5 박근칠 2020
37626 Multidisciplinary Sciences Regulatory -(FoxP3(+)) T cells and TGF-beta predict the response to an... SCI REP-UK 2020 10.1038/s41598-020-76130-1 박근칠 2020
37625 Oncology Ramucirumab or placebo plus erlotinib inEGFR-mutated, metastatic non-s... CANCER SCI 2020 10.1111/cas.14655 박근칠 2020
37624 Oncology Ramucirumab and durvalumab for previously treated, advanced non-small-... EUR J CANCER 2020 10.1016/j.ejca.2020.06.007 박근칠 2020
37623 Oncology Phase III study of selpercatinib vs chemotherapy plus /- pembrolizumab... FUTURE ONCOL 2020 10.2217/fon-2020-0935 박근칠 2020
37622 Oncology; Respiratory System Osimertinib Improves Overall Survival in Patients With EGFR-Mutated NS... J THORAC ONCOL 2020 10.1016/j.jtho.2020.06.018 박근칠 2020